CEP
AMGN icon

Chicago Equity Partners’s Amgen AMGN Stock Holding History

Chicago Equity Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$862K Buy
4,250
+645
+18% +$141K 0.09% 311
2019
Q4 		$869K Sell
3,605
-18,440
-84% -$4.06M 0.05% 500
2019
Q3 		$4.27M Sell
22,045
-25,785
-54% -$4.95M 0.2% 142
2019
Q2 		$8.81M Sell
47,830
-21,385
-31% -$3.83M 0.39% 47
2019
Q1 		$13.1M Sell
69,215
-10,085
-13% -$1.93M 0.51% 34
2018
Q4 		$15.4M Sell
79,300
-13,460
-15% -$2.63M 0.62% 25
2018
Q3 		$19.2M Sell
92,760
-2,235
-2% -$440K 0.57% 29
2018
Q2 		$17.5M Sell
94,995
-125
-0.1% -$22.1K 0.54% 27
2018
Q1 		$16.2M Sell
95,120
-700
-0.7% -$128K 0.52% 30
2017
Q4 		$16.7M Sell
95,820
-19,890
-17% -$3.52M 0.51% 39
2017
Q3 		$21.6M Sell
115,710
-73,475
-39% -$13M 0.68% 19
2017
Q2 		$32.6M Sell
189,185
-3,780
-2% -$615K 0.88% 12
2017
Q1 		$31.7M Sell
192,965
-34,235
-15% -$5.69M 0.91% 15
2016
Q4 		$33.2M Buy
227,200
+3,500
+2% +$527K 0.88% 19
2016
Q3 		$37.3M Buy
223,700
+26,155
+13% +$4.42M 1.03% 14
2016
Q2 		$30.1M Buy
197,545
+66,675
+51% +$10.4M 0.88% 20
2016
Q1 		$19.6M Sell
130,870
-37,880
-22% -$5.63M 0.57% 53
2015
Q4 		$27.4M Sell
168,750
-12,955
-7% -$2.04M 0.73% 33
2015
Q3 		$25.1M Buy
181,705
+13,685
+8% +$2.16M 0.7% 40
2015
Q2 		$25.8M Buy
168,020
+159,330
+1,833% +$25.5M 0.7% 43
2015
Q1 		$1.39M Buy
8,690
+740
+9% +$117K 0.04% 243
2014
Q4 		$1.27M Buy
+7,950
New +$1.24M 0.03% 254
2014
Q2 		– Sell
-20,037
Closed -$2.47M – 444
2014
Q1 		$2.47M Sell
20,037
-344,062
-94% -$41.7M 0.07% 199
2013
Q4 		$41.5M Sell
364,099
-23,914
-6% -$2.72M 1.25% 14
2013
Q3 		$43.4M Sell
388,013
-40,010
-9% -$4.34M 1.34% 10
2013
Q2 		$42.2M Buy
+428,023
New +$44.4M 1.31% 12

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chicago Equity Partners's AMGN Position: Q1 2020 in Review

Chicago Equity Partners increased its Amgen (AMGN) stake by 18% in Q1 2020, buying an estimated $141K and bringing the position to 4,250 shares worth $862K. The position accounts for 0.09% of the portfolio, ranked #311.

Chicago Equity Partners first reported a position in AMGN in Q2 2013 and has held it in 26 quarters since. The position peaked at $43.4M in Q3 2013. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Chicago Equity Partners held 4,250 shares of Amgen worth $862K as of Q1 2020.
  • Chicago Equity Partners bought 645 Amgen shares in Q1 2020, an estimated $141K.
  • Amgen made up 0.09% of Chicago Equity Partners's portfolio in Q1 2020, its #311 holding.
  • Chicago Equity Partners first reported a position in Amgen in Q2 2013 and has held it in 26 quarters since.
  • Chicago Equity Partners's Amgen position peaked at $43.4M in Q3 2013.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.